Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Debt / NOTE 1.000%11/1
-
Number of holders
-
0
-
Total 13F principal, excl. options
-
0
-
Principal change
-
-49,835,500
-
Total reported value, excl. options
-
$0
-
Value change
-
-$49,938,000
-
Number of sells
-
-18
Significant Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 as of Q4 2021
18 filings reported holding 464337AJ3 - ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 as of Q4 2021.
ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 has 0 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $0 of principal
.
Largest 10 bondholders include Russell Investments Group, Ltd. ($0 of principal), GIRARD PARTNERS LTD. ($0 of principal), Steward Partners Investment Advisory, LLC ($0 of principal), RAYMOND JAMES & ASSOCIATES ($0 of principal), PALISADE CAPITAL MANAGEMENT LLC/NJ ($0 of principal), AVANTAX ADVISORY SERVICES, INC. ($0 of principal), MACKAY SHIELDS LLC ($0 of principal), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($0 of principal), CITIGROUP INC ($0 of principal), and Rockefeller Capital Management L.P. ($0 of principal).
This table shows the top 0 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.